Researchers at the Hospital for Sick Children in Toronto, Canada, and Life Technologies will collaborate on a project that will use the SOLiD technology to study the genomic basis of autism spectrum disorder, the partners said last week.
The researchers, led by Stephen Scherer, were awarded CA$8.9 million ($8.8 million) from the Global Leadership Round in Genomics and Life Sciences — a CA$114 million program of the Ontario Research Fund by the Ministry of Research and Innovation — last week for a project to develop new tools to screen genomes and diagnose ASD and other neurological disorders.
Under the collaboration, Life Technologies will provide a SOLiD instrument, which will join two SOLiD systems previously purchased by the Hospital for Sick Children. The hospital said that the value of the instrument is CA$700,000.
The instrument will be used "to sequence genes from thousands of ASD patients in Ontario," according to a statement from the hospital.